Toggle navigation
Catalyst Capital
Home
About
Overview
Guiding Principles
Community
Case Studies
Awards & Recognition
Our Team
Portfolio
News
Contact Us
Investor Login
News
Evolve Biologics, Therapure Biopharma’s Biologics Division, Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
March 2018
/ Author: elissa
March 28, 2018 – Business Wire